---
title: Charlie Plauche
date: 2018-12-07 09:44:50 -0600
description: ''
photo: https://res.cloudinary.com/health-wildcatters/image/upload/v1544197509/image.png
link_1: ''
link_2: ''
link_3: ''
link_4: ''
published: false

---
Charlie Plauche is a Partner at S3 Ventures.  Charlie currently serves on the boards of S3 portfolio companies Alkami Technology, Iconixx, OutboundEngine, Tango Health, and z-lien.  He also works closely with S3’s investments in AllStacks, Chrono.gg, and Liveoak Technologies. Previous board duties include Favor Delivery (acquired by H-E-B), Kimbia (acquired by GiveGab) and Pristine (acquired by Upskill).  Charlie also worked closely with TVA Medical (acquired by Becton Dickinson, NYSE:BDX). 

Prior to S3, Charlie was with Harbert Private Equity Funds, a subsidiary of Harbert Management Corporation.  At Harbert, Charlie analyzed and structured leveraged buyouts in the healthcare and manufacturing sectors and assisted with portfolio management.  He received his MBA from the McCombs School at the University of Texas in Austin and his BS in Finance from the University of Mississippi, where he was a Holmes Scholarship recipient and a Mississippi Eminent Scholar.